Quick answers
- What is Bacitracin zinc and polymyxin b sulfate used for?
- The FDA-approved label (Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, March 17, 2026) says: “For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- What are the side effects of Bacitracin zinc and polymyxin b sulfate?
- The “Adverse Reactions” section of the FDA label (Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, March 17, 2026) begins: “To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Bacitracin zinc and polymyxin b sulfate have a boxed warning?
- No. None of the 5 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Bacitracin zinc and polymyxin b sulfate?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
- Has Bacitracin zinc and polymyxin b sulfate been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Bacitracin zinc and polymyxin b sulfate?
- 3 companies list prescription products of Bacitracin zinc and polymyxin b sulfate in the FDA NDC Directory, including A-S Medication Solutions, NuCare Pharmaceuticals, Inc. and Bausch & Lomb Incorporated.
What Bacitracin zinc and polymyxin b sulfate is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.
— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →
Label quoted: the one for the most common form (ointment, ophthalmic), Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.
The FDA has 5 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 5 FDA labels for this medicine have a boxed warning.
Bacitracin zinc and polymyxin b sulfate side effects
Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.
To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →
Bacitracin zinc and polymyxin b sulfate dosage
Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.
Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection. FOR OPHTHALMIC USE ONLY
— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →
When Bacitracin zinc and polymyxin b sulfate should not be used
Quoted from the “Contraindications” section of the FDA-approved label.
This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.
— FDA label: Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026. Read the full label on DailyMed →
Forms and how it is given
| Dosage forms | Ointment |
|---|---|
| Route | Ophthalmic |
| Prescription products | 5 in the FDA NDC Directory |
| Brand names | Polycin |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| bacitracin zinc 500 USP units/g · polymyxin b sulfate 10000 USP units/g ointment | Generic | $2.82 per gram |
NADAC list of November 11, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- A-S Medication Solutions2 products
- NuCare Pharmaceuticals, Inc.2 products
- Bausch & Lomb Incorporated1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (2)
- ANDA064046Bausch and Lomb Inc · January 26, 1995
- ANDA065022Padagis Us · February 27, 2002
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 213621, 308511 |
|---|---|
| SPL set ID of the quoted label | 51f6eac3-205e-4beb-8522-6ba2c593f350 |
| FDA labels (SPL) | 5 |
| FDA applications | 2 ANDA |
| Active ingredients (FDA) | BACITRACIN ZINC / POLYMYXIN B SULFATE |
Next steps
- Find a pharmacy near youAsk which price applies to you and whether your product is affected by a recall
- Latest FDA drug recallsAll medicines, newest first
- Bacitracin zinc and polymyxin b sulfate sold over the counterDrug Facts label and store brands
- PolycinBrand page: products, maker and price
- A-S Medication SolutionsMaker or distributor
- NuCare Pharmaceuticals, Inc.Maker or distributor
- Bausch & Lomb IncorporatedMaker or distributor
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Bacitracin Zinc and Polymyxin B Sulfate, A-S Medication Solutions, effective March 17, 2026; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →